Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 201 results found. Search for [ Bayer ]

Results 160 to 180 of 201
www.businesstoday.in
December 11, 2012
Sir Richard Branson will still own more than half of Virgin Atlantic, which will continue to fly as a separate airline under its own name.


E. Kumar Sharma
November 29, 2012
The Intellectual Property Appellate Board's decision to deny patent protection to AstraZeneca for its lung cancer drug Gefitinib is the latest setback for global pharmaceutical companies in India.


BT Online Bureau
New Delhi, November 29, 2012
Intellectual Property Appellate Board (IPAB) has again turned down drug firm AstraZeneca's plea for a patent on the lung cancer drug Gefitinib.


E. Kumar Sharma
November 23, 2012
The deal, when concluded, will give Cipla more access to the region and a direct, customer-facing presence in a key export market. Medpro would be the biggest international acquisition by the company, though not the first - officials confirm that its already has stakes in some foreign companies.


PTI
New Delhi, November 8, 2012
The pharma company slashed prices of its three generic cancer drugs - Erlocip, Docetax and Capegard - by up to 64 per cent.


E. Kumar Sharma
November 4, 2012
India's Intellectual Property Appellate Board has revoked the patent granted in India to F. Hoffmann-La Roche AG (Roche) for pegylated interferon alfa-2a, a medicine used to treat hepatitis C, citing lack of evidence that the drug was better than existing treatments available in the market.


Team BT
October 9, 2012
Of late, the heads of a number of regulatory bodies have been flexing their muscles in different ways, using the full extent of their powers in a manner their predecessors had never done.


BT Online Bureau
August 22, 2012
The Supreme Court will hear final arguments from in a key patent dispute between Swiss drugmaker Novartis and India's patent office September 11.


www.businesstoday.in
May 24, 2012
There seems to be no end to the Air India mess, with pilots demanding exclusive training rights on Dreamliner jet planes.


www.businesstoday.in
June 7, 2012
Starring: J.S. Sarma, Rahul Khullar, Dev Amritesh, Y.K. Hamied, Hiroyuki Suzuki, Pallavi Jha


Mail Today Bureau
Mumbai, May 17, 2012
The Mumbai-based company, flushed with cash after it sold formulations business to US-based Abbott Laboratories for $3.72 billion in 2010, will acquire healthcare data provider Decision Resources Group (DRG) for $635 million (Rs 3,400 crore).


PTI
Berlin, May 10, 2012
Bayer holds the patent for Nexavar till 2020 and it will \"vigorously defend its patent within the available legal framework\".


PTI
New Delhi, May 7, 2012
In March this year, India had invoked a law permitting Hyderabad-based Natco Pharma to manufacture and sell cancer-treatment drug Nexavar at a price over 30 times lower than charged by its patent-holder Bayer Corporation.


E Kumar Sharma
Hyderabad, May 4, 2012
Cipla says that its decision to slash prices of cancer drugs is purely a humanitarian gesture. In cancer treatment, it is planning to do what it did in anti-AIDS drugs many years ago by launching them at low prices.


PTI
New Delhi, May 3, 2012
Cipla Chairman and MD YK Hamied said, \"This initiative of price reduction is a humanitarian approach by Cipla to support cancer patients.\"


Associated Press
New York, April 18, 2012
Nestle is one of the world's largest sellers of infant formula and may face some antitrust hurdles to complete the deal, according to a report in The Wall Street Journal.


Suman Layak and Geetanjali Shukla
April 12, 2012
Harsh Goenka, chairman, RPG Enterprises, in a free-wheeling, nearly two-hour-long, chat with Business Today's Suman Layak and Geetanjali Shukla discusses his companies' overseas plans.


Dinesh C. Sharma
New Delhi, March 28, 2012
The landmark decision of the patent office to break the monopoly of Bayer in kidney and liver cancer drugs recently is already having a rippling effect.


E. Kumar Sharma
March 27, 2012
Compulsory licences have brought domestic and multinational pharma companies face to face. Although domestic firms are getting to make cheaper versions of patented drugs, will this be enough to cure the country of its health care ills?


E Kumar Sharma
March 13, 2012
This is the first time an Indian company has been granted a compulsory licence, which means the patent holders grant licences to generic drug makers.


PAGES 9 OF 11  678910